Is universal better than selective immunization in developing world? Vaccines (HBV)
- PMID: 12294767
Is universal better than selective immunization in developing world? Vaccines (HBV)
Abstract
PIP: Rumi et al. conducted a study to estimate the economic rationale for introducing routine prenatal hepatitis B surface antigen (HBsAg) screening and prescribing combined passive-active immunization to at-risk babies in Bangladesh. They concluded that universal hepatitis B virus (HBV) immunization may be more cost-effective than selective immunization in developing countries such as Bangladesh and India, and have therefore called for the replacement of selective vaccination with universal vaccination in Bangladesh. Given the limited available facilities in Bangladesh for antenatal checkup and laboratory tests, the universal vaccination of newborns is the more simple logistical option to control HBV infection. The Global Advisory Group of the Expanded Program on Immunization and World Health Assembly has recommended that countries with higher than a 2% prevalence of HBV carriers add hepatitis B vaccine to their routine infant immunization schedules. In the Southeast Asian region, however, only Indonesia, Mongolia, Thailand, and the Maldives have begun such routine hepatitis B immunization. Economic constraints have prevented other countries in the region from following suit.
Similar articles
-
Immunoprophylaxis of hepatitis B virus infection.Indian J Med Microbiol. 2001 Oct-Dec;19(4):172-83. Indian J Med Microbiol. 2001. PMID: 17664829
-
[Hepatitis B vaccine: a new force against pandemic diseases].Foro Mund Salud. 1990;11(2):165-8. Foro Mund Salud. 1990. PMID: 12179351 Spanish.
-
Vaccine requirements and priorities for developing countries.J Med Assoc Thai. 1986 Sep;69(9):505-10. J Med Assoc Thai. 1986. PMID: 3794567
-
Hepatitis B vaccination in countries with low endemicity.Prescrire Int. 2000 Feb;9(45):213-9. Prescrire Int. 2000. PMID: 11503803 Review.
-
Screening for hepatitis A and B antibodies in patients with chronic liver disease.Am J Med. 2005 Oct;118 Suppl 10A:28S-33S. doi: 10.1016/j.amjmed.2005.07.014. Am J Med. 2005. PMID: 16271538 Review.
Cited by
-
Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment.Pediatrics. 2013 Apr;131(4):e1135-43. doi: 10.1542/peds.2012-1262. Epub 2013 Mar 25. Pediatrics. 2013. PMID: 23530168 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical